Naturalness Preserved Image Enhancement Using a priori Multi-Layer Lightness Statistics

Por Wang, Shuhang, Luo, Gang
Publicado no IEEE Trans Image Process (2017)

Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer

Por Wang, Shuhang, Cang, Shundong, Liu, Delong
Publicado no J Hematol Oncol (2016)

Clinical applications of PD-L1 bioassays for cancer immunotherapy

Por Liu, Delong, Wang, Shuhang, Bindeman, Wendy
Publicado no J Hematol Oncol (2017)

Detection of Lane-Change Events in Naturalistic Driving Videos

Por Wang, Shuhang, Ott, Brian R., Luo, Gang
Publicado no Intern J Pattern Recognit Artif Intell (2018)

EGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancer

Por Wang, Shuhang, Tsui, Stella T., Liu, Christina, Song, Yongping, Liu, Delong
Publicado no J Hematol Oncol (2016)

Data Aggregation Based on Overlapping Rate of Sensing Area in Wireless Sensor Networks

Por Tang, Xiaolan, Xie, Hua, Chen, Wenlong, Niu, Jianwei, Wang, Shuhang
Publicado no Sensors (Basel) (2017)

Dynamic gaze-position prediction of saccadic eye movements using a Taylor series

Por Wang, Shuhang, Woods, Russell L., Costela, Francisco M., Luo, Gang
Publicado no J Vis (2017)

Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR

Por Wang Fen, Wang Shuhang, Wang Zhijie, Duan Jianchun, An Tongtong, Zhao Jun, Bai Hua, Wang Jie
Publicado em 2012-08-01

Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR

Por Wang, Fen, Wang, Shuhang, Wang, Zhijie, Duan, Jianchun, An, Tongtong, Zhao, Jun, Bai, Hua, Wang, Jie
Publicado em 2012

A phase I study of nimotuzumab plus docetaxel in chemotherapy-refractory/resistant patients with advanced non-small-cell lung cancer

Por Zhao, Jun, Zhuo, Minglei, Wang, Zhijie, Duan, Jianchun, Wang, Yuyan, Wang, Shuhang, An, Tongtong, Wu, Meina, Wang, Jie
Publicado no Chin J Cancer Res (2016)

Detection of Risky Driving Behaviors in the Naturalistic Environment in Healthy Older Adults and Mild Alzheimer’s Disease

Por Davis, Jennifer D., Wang, Shuhang, Festa, Elena K., Luo, Gang, Moharrer, Mojtaba, Bernier, Justine, Ott, Brian R.
Publicado no Geriatrics (Basel) (2018)

Analysis of EGFR mutation status in tissue and plasma for predicting response to EGFR-TKIs in advanced non-small-cell lung cancer

Por Wang, Yuyan, Duan, Jianchun, Chen, Hanxiao, Bai, Hua, An, Tongtong, Zhao, Jun, Wang, Zhijie, Zhuo, Minglei, Wang, Shuhang, Wang, Jie
Publicado no Oncol Lett (2017)

Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer

Por Wang, Shuhang, An, Tongtong, Duan, Jianchun, Zhang, Lijian, Wu, Meina, Zhou, Qinghua, Chen, Jinfeng, Zhuo, Minglei, Yang, Lu, Wang, Yuyan, Bai, Hua, Wang, Jie
Publicado em 2013

Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC

Por Wang, Zhijie, Chen, Rui, Wang, Shuhang, Zhong, Jia, Wu, Meina, Zhao, Jun, Duan, Jianchun, Zhuo, Minglei, An, Tongtong, Wang, Yuyan, Bai, Hua, Wang, Jie
Publicado no PLoS One (2014)

Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation

Por Wang, Shuhang, Su, Xiaomei, Bai, Hua, Zhao, Jun, Duan, Jianchun, An, Tongtong, Zhuo, Minglei, Wang, Zhijie, Wu, Meina, Li, Zhenxiang, Zhu, Jian, Wang, Jie
Publicado no J Hematol Oncol (2015)

DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer

Por Zhu, Jian, Wang, Yuyan, Duan, Jianchun, Bai, Hua, Wang, Zhijie, Wei, Lai, Zhao, Jun, Zhuo, Minglei, Wang, Shuhang, Yang, Lu, An, Tongtong, Wu, Meina, Wang, Jie
Publicado em 2012

ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations

Por Wang, Zhijie, Li, Zhenxiang, Ding, Xiaosheng, Shen, Zhirong, Liu, Zhentao, An, Tongtong, Duan, Jianchun, Zhong, Jia, Wu, Meina, Zhao, Jun, Zhuo, Minglei, Wang, Yuyan, Wang, Shuhang, Sun, Yu, Bai, Hua, Wang, Jie
Publicado no Sci Rep (2015)

Survival difference between EGFR Del19 and L858R mutant advanced non-small cell lung cancer patients receiving gefitinib: a propensity score matching analysis

Por Zhuo, Minglei, Zheng, Qiwen, Zhao, Jun, Wu, Meina, An, Tongtong, Wang, Yuyan, Li, Jianjie, Wang, Shuhang, Zhong, Jia, Yang, Xue, Chen, Hanxiao, Jia, Bo, Dong, Zhi, Gao, Emei, Wang, Jingjing, Wang, Ziping
Publicado no Chin J Cancer Res (2017)

Influence of body mass index on the therapeutic efficacy of gemcitabine plus cisplatin and overall survival in lung squamous cell carcinoma

Por Zhong, Jia, Zheng, Qiwen, Gao, Emei, Dong, Zhi, Zhao, Jun, An, Tongtong, Wu, Meina, Zhuo, Minglei, Wang, Yuyan, Li, Jianjie, Wang, Shuhang, Yang, Xue, Chen, Hanxiao, Jia, Bo, Wang, Jingjing, Wang, Ziping
Publicado no Thorac Cancer (2018)

Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non–Small-Cell Lung Cancer

Por Bai, Hua, Wang, Zhijie, Chen, Keneng, Zhao, Jun, Lee, J. Jack, Wang, Shuhang, Zhou, Qinghua, Zhuo, Minglei, Mao, Li, An, Tongtong, Duan, Jianchun, Yang, Lu, Wu, Meina, Liang, Zhen, Wang, Yuyan, Kang, Xiaozheng, Wang, Jie
Publicado no J Clin Oncol (2012)